Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion type Assertion NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_head.
- NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion description "[The percent of patients who were free of recurrence with ss-blocker therapy was higher and the death rate was lower among LQT1 patients (81% and 4%, respectively) than among LQT2 (59% and 4%, respectively) and LQT3 (50% and 17%, respectively) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_provenance.
- NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion evidence source_evidence_literature NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_provenance.
- NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion SIO_000772 11136691 NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_provenance.
- NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion wasDerivedFrom befree-20140225 NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_provenance.
- NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion wasGeneratedBy ECO_0000203 NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_provenance.